Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The ...

Gilead Sciences, Inc. today announced new data from multiple analyses which reinforce that Livdelzi® (seladelpar), known as Lyvdelzi® in the European Union, is effective and generally well-tolerated ...

Adequate biliary drainage should remain the principal aim of cholangiography. In the absence of clear evidence of systemic sepsis, antibiotics should not be prescribed or changed purely according ...

Georgia Southwestern University Georgia Southwestern State University (GSW) hosted its 7th Annual Undergraduate Research ...

Biliary stasis inhibits the continuous flushing activity of ... bacteria and toxins out of the ducts and into the systemic circulation, which can result in sepsis. Sepsis is among the most common ...

A retrospective analysis using the updated definition of sepsis-associated acute kidney injury (SA-AKI) reported this condition affects nearly half of patients admitted to the intensive care unit ...

Tom Britain and wife Angela of Ridgefield make lunch, something Tom was unable to do while recovering from sepsis and an appendectomy. He and Angela, who has a doctorate in nursing, discuss the ...

The father of a woman from Jersey who had all four limbs amputated after getting sepsis said "no father is prouder than I am", after a 10km fundraising run was held for his daughter. Medical ...

MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC).